smithery.ai
admet-prediction
ADMET (Absorption, Distribution, Metabolism, Excretion, Toxicity) prediction for drug candidates. Use for assessing drug-likeness, PK properties, and safety risks early in drug discovery.
Use judgment
Installs
1
Stars
—
Security
No audit
Freshness
Unknown
Updated
—
First seen Apr 25, 2026
Installation
Project
Global
$
npx skills add https://smithery.ai
Copy
SKILL.md
ADMET Prediction Skill
Predict ADMET properties to prioritize compounds for development.
Quick Start
/admet "CC1=CC=C(C=C1)CNC" --full
/pk-prediction --library compounds.sdf --threshold 0.7
/toxicity-screen CHEMBL210 --include hERG,DILI,Ames
What's Included
Property
Prediction
Model
Absorption
Caco-2, HIA, Pgp
ML/QSAR
Distribution
VDss, PPB, BBB
ML/QSAR
Metabolism
CYP inhibition, clearance
ML/QSAR
Excretion
Clearance, half-life
ML/QSAR
Toxicity
hERG, DILI, Ames, mutagenicity
ML/QSAR
Output Structure
# ADMET Profile: CHEMBL210 (Osimertinib)
## Summary
| Property | Value | Status |
|----------|-------|--------|
| Drug-likeness | Pass | ✓ |
| Lipinski Ro5 | 0 violations | ✓ |
| VEBER | Pass | ✓ |
| PAINS | 0 alerts | ✓ |
| Brenk | 0 alerts | ✓ |
## Absorption
| Property | Prediction | Confidence |
|----------|------------|-------------|
| HIA | 98% | High |
| Caco-2 | 15.2 × 10⁻⁶ cm/s | High |
| Pgp substrate | Yes | Medium |
| F30% | 65% | Medium |
## Distribution
| Property | Prediction | Confidence |
|----------|------------|-------------|
| VDss | 5.2 L/kg | Medium |
| PPB | 95% | High |
| BBB | Yes | High |
| CNS MPO | 5.5 | Good |
## Metabolism
| Property | Prediction | Confidence |
|----------|------------|-------------|
| CYP3A4 substrate | Yes | High |
| CYP3A4 inhibitor | Yes | Medium |
| CYP2D6 inhibitor | No | High |
| CYP2C9 inhibitor | No | Medium |
| Clearance | 8.5 mL/min/kg | Low |
## Excretion
| Property | Prediction | Confidence |
|----------|------------|-------------|
| Renal clearance | 10% | Medium |
| Half-life | 48 hours | High |
## Toxicity
| Property | Prediction | Confidence |
|----------|------------|-------------|
| hERG inhibition | No | High |
| DILI | Concern | Medium |
| Ames mutagenicity | Negative | High |
| Carcinogenicity | Negative | Medium |
| Respiratory toxicity | No | Low |
## Recommendations
**Strengths**:
- Good oral bioavailability (65%)
- Brain penetration (BBB permeable)
- Low hERG risk
**Concerns**:
- DILI concern - monitor in preclinical studies
- CYP3A4 inhibition - potential DDIs
**Overall**: Good ADMET profile. Progress to in vivo PK.
Property Ranges
Drug-Likeness
Rule
Pass Criteria
Lipinski Ro5
≤ 1 violation
Veber
RotB ≤ 10, PSA ≤ 140 Ų
Egan
LogP ≤ 5, PSA ≤ 131 Ų
MDDR
MW ≤ 600, LogP ≤ 5
Absorption
Property
Good
Moderate
Poor
HIA
>80%
40-80%
<40%
Caco-2
>10
1-10
<1
F30%
>70%
30-70%
<30%
Distribution
Property
Good
Moderate
Poor
VDss
0.3-5 L/kg
<0.3 or >5
Extreme
PPB
<90%
90-95%
>95%
BBB
LogBB > 0.3
-0.3 to 0.3
< -0.3
Toxicity Alerts
Alert
Action
hERG inhibition
Cardiotoxicity risk
DILI positive
Hepatotoxicity risk
Ames positive
Mutagenicity risk
PAINS
Assay interference
Structural alerts
Investigate further
Running Scripts
# Full ADMET profile
python scripts/admet_predict.py --smiles "CC1=CC=C..." --full
# Batch prediction
python scripts/admet_predict.py --library compounds.sdf --output results.csv
# Specific properties
python scripts/admet_predict.py --smiles "..." --properties hERG,DILI,CYP
# Filter by criteria
python scripts/admet_filter.py --library compounds.sdf --rules lipinski,veber
Requirements
pip install rdkit
# Optional for advanced models
pip install deepchem admet-x
Reference
[reference/admet-properties.md](reference/admet-properties.md) - Detailed property reference
[reference/toxicity-alerts.md](reference/toxicity-alerts.md) - Toxicity alerts reference
[reference/pk-models.md](reference/pk-models.md) - PK prediction models
Best Practices
Use multiple models : Consensus predictions more reliable
Check confidence : Low confidence = experimental verification needed
Consider chemistry : Novel structures less reliable
Iterative design : Use predictions to guide synthesis
Validate early : Confirm key predictions experimentally
Common Pitfalls
Pitfall
Solution
Over-reliance on predictions
Experimental validation required
Ignoring confidence
Check model applicability domain
Single model only
Use consensus of multiple models
Ignoring chemistry
Novel scaffolds = uncertain predictions
Late-stage testing
Early ADMET screening saves time
Limitations
Models are approximate : Errors common
Novel chemistry : Less reliable for new scaffolds
In vitro-in vivo gap : Predictions don't always translate
Species differences : Human predictions based on animal data
Complex mechanisms : Some toxicity not predicted